Diagnostic validation and prognostic implications of serial 0/1/3h stratification in patients with suspected myocardial infarction using high-sensitivity troponin T.
📚 期刊: Eur Heart J Qual Care Clin Outcomes📅 发表: 2026-01-01🔬 PMID: 42013281🔗 DOI:10.1093/ehjqcco/qcag062👁️ 浏览: 79
👤 作者: Lehmacher Jonas, Toprak Betül, Sörensen Nils Arne, Guo Linlin, Haller Paul Michael, Schock Alina, Thießen Niklas, Scharlemann Lea, Völschow Ben, Zeller Tanja, Neumann Johannes Tobias, Twerenbold Raphael
冠心病
📑 引用格式
APAVancouver国标 GB/T 7714BibTeXRIS
Lehmacher Jonas, Toprak Betül, Sörensen Nils Arne, Guo Linlin, Haller Paul Michael, Schock Alina, Thießen Niklas, Scharlemann Lea, Völschow Ben, Zeller Tanja, Neumann Johannes Tobias, Twerenbold Raphael (2026). Diagnostic validation and prognostic implications of serial 0/1/3h stratification in patients with suspected myocardial infarction using high-sensitivity troponin T.. Eur Heart J Qual Care Clin Outcomes. https://doi.org/10.1093/ehjqcco/qcag062
🔗 分享文献
📝 摘要
The European Society of Cardiology (ESC) recommends 0/1h-algorithms for triage of patients with suspected myocardial infarction (MI). Recently, cut-offs allowing 3h triage using high-sensitivity cardiac troponin T (hs-cTnT) have been derived, but their prognostic implications remain unclear, and external validation is lacking. To externally validate the diagnostic performance and assess the prognostic impact of the 0/1/3h algorithm for cardiovascular events in an all-comer cohort with suspected MI. We prospectively enrolled patients presenting to the emergency department with suspected MI. hs-cTnT was measured at presentation, 1h, and 3h. Patients were followed up to evaluate all-cause mortality and major adverse cardiovascular events (MACE). Diagnostic accuracy was assessed by stratifying patients using the 0/1/3h algorithm. Cox regression analyses compared cardiovascular risk at 90 days and three years between rule-in and rule-out groups. Among 2,514 patients (median age 64 years; 63.6% men), the algorithm demonstrated excellent rule-out safety (sensitivity 98.6% [95% CI, 96.8, 99.4]; NPV 99.7% [99.2, 99.9]) and moderate rule-in capacity (specificity 89.3% [87.9, 90.5]; PPV 60.8% [56.8, 64.7]). Over three years, 646 patients experienced MACE, and 256 died (68 cardiac deaths). Patients ruled-out at 3h had doubled MACE risk (HR 2.11 [1.44, 3.08]) and quadrupled mortality risk (HR 4.33 [1.85, 10.12]) compared to immediate rule-out (p<0.001). The 0/1/3h algorithm shows excellent diagnostic safety and adds prognostic value, with delayed rule-out associated with significantly increased long-term cardiovascular risk and mortality.